A Genome-wide Linkage Study Of Schizophrenia In A Large Sample From Tamil Nadu, India
Funder
National Health and Medical Research Council
Funding Amount
$500,000.00
Summary
A Study of Schizophrenia in Tamil Nadu, India. The cause of schizophrenia is unknown, but there is good evidence that genes play a role. Geneticists do not fully understand how the disease is inherited, but it is very complex, and several interacting genes as well as environmental factors are probably involved. We have been recruiting families with at least two siblings with schizophrenia from a number of communities-casts in Tamil Nadu. We plan to recruit a total of 400 affected sibling familie ....A Study of Schizophrenia in Tamil Nadu, India. The cause of schizophrenia is unknown, but there is good evidence that genes play a role. Geneticists do not fully understand how the disease is inherited, but it is very complex, and several interacting genes as well as environmental factors are probably involved. We have been recruiting families with at least two siblings with schizophrenia from a number of communities-casts in Tamil Nadu. We plan to recruit a total of 400 affected sibling families, together with 400 trio families (both parents, plus their affected child). A genome-wide scan of the genetic code in all individuals will be conducted to identify chromosomal regions linked to schizophrenia. This is the first necessary step toward identifying schizophrenia susceptibility genes. If one or more genes are discovered, this will greatly improve our understanding of this disease. It will also stimulate the search for similar genes in other samples world-wide, including Australia where schizophrenia costs $2.5 billion annually in terms of treatment and loss of employment. With such a discovery, it may be possible to find better treatments that correct the basic cause of the illness and identify factors that protect against the illness.Read moreRead less
Neonatal Vitamin D Status And Risk Of Schizophrenia: A Study Using Danish Dried Bloods Spots
Funder
National Health and Medical Research Council
Funding Amount
$164,980.00
Summary
There is increasing evidence that low levels of vitamin D (i.e. the 'sunshine hormone') during early development can alter brain development. In particular, it has been proposed that low vitamin D during development (e.g. prenatal and in early life), increases the risk of developing schizophrenia during adulthood. A previous study based on stored third trimester blood samples from US women suggested that very low levels of maternal vitamin D may be associated with an increased risk of schizophre ....There is increasing evidence that low levels of vitamin D (i.e. the 'sunshine hormone') during early development can alter brain development. In particular, it has been proposed that low vitamin D during development (e.g. prenatal and in early life), increases the risk of developing schizophrenia during adulthood. A previous study based on stored third trimester blood samples from US women suggested that very low levels of maternal vitamin D may be associated with an increased risk of schizophrenia in the offspring. We have the opportunity to explore this hypothesis using a large, well-described Danish 'bio-bank'. Since 1981, blood samples from newborn babies have been kept by a central agency in Denmark. In collaboration with senior Danish medical researchers, 900 blood samples of babies who have subsequently developed schizophrenia and 1800 from matched healthy individuals have been identified. We will measure vitamin D levels in these blood samples. We predict that babies with low levels of vitamin D will have an increased risk of developing schizophrenia. If low prenatal vitamin D does increase the risk of schizophrenia, this finding will have important implications from a public health perspective. Just as the number of infants affected by spina bifida has been reduced by adding folate supplements to foods, optimizing maternal vitamin D levels may lead to a reduction in the incidence of schizophrenia.Read moreRead less
An Integrated Psychoacoustic And High-field FMRI Study Of Auditory Temporal Processsing Dysfunction In Schiophrenia.
Funder
National Health and Medical Research Council
Funding Amount
$306,000.00
Summary
This research seeks to improve our understanding of the causes of brain dysfunction in schizophrenia. This chronic and debilitating psychiatric disorder is usually accompanied by dramatic symptoms such as hallucinations, delusions, paranoia and disordered patterns of thinking. Based on our interpretation of evidence from a number of fields of schizophrenia research we suspect that the brain dysfunction in schizophrenia may not in the brain areas responsible for those dramatic symptoms but occurs ....This research seeks to improve our understanding of the causes of brain dysfunction in schizophrenia. This chronic and debilitating psychiatric disorder is usually accompanied by dramatic symptoms such as hallucinations, delusions, paranoia and disordered patterns of thinking. Based on our interpretation of evidence from a number of fields of schizophrenia research we suspect that the brain dysfunction in schizophrenia may not in the brain areas responsible for those dramatic symptoms but occurs initially in the very basic sensory regions of the brain. These regions can be thought of as providing the building blocks of our perceptions, that ultimately allow us to see, hear, smell and feel. Our previous research shows that people with schizophrenia have a very specific problem in the way that they perceive sounds. Using measures of brain activity, people with schizophrenia show consistent evidence that their brains do not process some of the timing information contained in sound. This is not the same as saying that people with schizophrenia are deaf, the deficits we see are much more subtle. It's a bit like the chaos theory analogy of a butterfly fluttering in Brazil and causing a typhoon in China. We think that very small alterations in brain activity in the initial stages of sensory processing can cascade through successively more complex stages of the brain, eventually creating the psychotic storm that becomes evident as the primary symptoms of schizophrenia. The brain regions we are interested in are located down at the base of the brain, in the brainstem, and it is only recently that the technology and methods of analysis we need to look at this activity have been developed. In this research we will be using functional magnetic resonance imaging and sophisticated hearing tests to examine whether these brain regions show the alterations we expect. If so, this will mean that the brain dysfunction in schizophrenia is quite different to what is currently believed.Read moreRead less
Identifying EQTLs And Endophenotyping Known CNVs In A Large Australian Schizophrenia Sample
Funder
National Health and Medical Research Council
Funding Amount
$902,472.00
Summary
This study hopes to identify genetic code variations associated with an increased risk of schizophrenia . We will study variation in gene expression levels in patients and healthy controls to identify underlying changes in the genetic code responsible. In a subset of patients with schizophrenia and known rare copy number variations (CNVs) in the genetic code we will conduct brain scans and psychological tests to characterize the effect of CNVs on brain structure and function in schizophrenia.